The key point I am making is that there are a bunch of

New Post Public Reply Private Reply Replies (1) Message Board
coolnapz Pay Zone #3228

The key point I am making is that there are a bunch of companies with little if any revenue for roughly 4 years or more. Think about it, 4 years with zero revenue. Treaty made 75,000 bucks last quarter and yet closed the week at the lowest it's been in over a year and a half. The company has more revenue production year to date than all of last year, yet trades below June of 2011 prices. It is also much further along on it's project and has more projects in the works than June of 2011.

This underscores the fact that a lot of this is speculation. For those that are losing heart with this start up E&P play, there are multiple examples of companies that are worse off when measured objectively by metrics such as revenue and oil production, but somehow get the benefit of the doubt even with years of non production.

Yeah, I understand that 10/1 ECCE had their PR. I'll concede a delayed reaction to news , but you would still have to concede the fact that it's pure blind speculation considering the lack of revenue and for that matter the declining production. They only have one producer and it's been a steep drop off each successive month. They have a well which has been in the works since 2010 but haven't even broken ground on it.

Next, ERHE, no money for about 10 years. That's 10 years of zero revenue on a 65 million dollar market cap. Maybe I missed something but I scanned back through the 10 K's and never saw any revenue. I saw one sale of a concession, which provided "other income" but I think that was in 2007 and that to me is a non recurring item. Wow, 10 years of no revenue.

I understand that they are fueling speculation for something big but to me that begs the question, why wouldn't the majors or some mid cap independent be on the case if this had a chance of a billion barrels? I mean CNOOC will build a soccer stadium and roads just to get on good terms with African leaders, why wouldn't they have been involved with this concession already? In any event, the key thing once again is that due to the lack of news or lack of revenue, the recent pop is a pure chart setup play as far as I can tell.

HDY - Once again, no money for nearly 4 years and guess what no money again for a couple of more. If we're supposed to gauge companies based on the proof being in the pudding, HDY should be trading well below 50 cents. I'm not denying that they had an impressive PR, but like I said based on revenue metrics it's hard to justify it's price. A half decade with zero revenue and with a ball park 5 year pay back period on any given well project, industry standard, that means that they likely won't turn a profit until nearly 2020 unless they hit it big. No thanks.

WGASD - They did a reverse about the time they were getting to the latter stages of the well completion. It said it was on a 24 hour production cycle, but I was under the impression that it was just a part of the later stages of the well completion. No sales announced yet though.

The thing that I have been told is that you can do all the seismic you want, but it's all academic until you break ground on that first exploratory well, complete, and start producing. Maybe Treaty's problem isn't that it wasn't too bold in it's scheduling and production projections, but rather that it has not been bold enough.

Once again, I just want people to get a perspective on this company by looking at lots of other E&P plays that have pissed away money year after year with little if anything to show for it yet somehow get a pop by announcing a great discovery in the making. If money talks and BS walks, a lot of companies are walking all the way to the bank with their market cap with even less oil than what Treaty has brought to market last quarter.

Treaty Energy Corporation (TECO) Stock Research Links

TECO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading

Top 5 Most Recently Viewed Articles

Celcuity Inc. Prepares for Third Quarter Financial Results

Updated Category News Views 91

Celcuity Inc. Announces Upcoming Financial Results Release Celcuity Inc. (NASDAQ: CELC), a pioneering biotechnology company focused on innovative oncology therapies, has exciting news. The company will be releasing its financial results for the third quarter of 2025 after the market closes. This significant event is scheduled for a Wednesday, with management set to...

Continue Reading
EverTrue and DonorSearch Team Up to Revolutionize Fundraising

Updated Category News Views 973

EverTrue's Strategic Acquisition of DonorSearch EverTrue, a leader in donor engagement and pipeline development, recently announced a significant acquisition. The company has acquired DonorSearch, known for its innovative AI-powered donor discovery solutions. This strategic move is aimed at enhancing the capabilities of fundraising teams, enabling them to connect with...

Continue Reading
Celebrating Creativity and Inclusion: ADCOLOR Awards 2025

Updated Category News Views 315

ADCOLOR Awards 2025: A Night of Inspiration and Celebration Presented by leading organizations in the industry like Amazon, Disney, and Meta, the ADCOLOR Awards is a prestigious event celebrating remarkable individuals and organizations that champion diversity and inclusion in creative fields. This year's ceremony showcased inspiring figures such as Richelieu Dennis,...

Continue Reading
Transforming a $1000 Investment in First Solar to $3700

Updated Category News Views 161

Transform Your Investment with First Solar First Solar (NASDAQ: FSLR) has shown impressive performance over the past decade. This company has not only managed to keep pace with the market but has actually outperformed it by an average of 2.49% annually. This impressive annualized return translates to an average annual growth of 14.22%, making First Solar a notable player...

Continue Reading
Carpenter Technology Announces New Quarterly Dividend Plans

Updated Category News Views 107

Carpenter Technology Announces Quarterly Cash Dividend Carpenter Technology Corporation (NYSE: CRS), a leading name in high-performance specialty alloys, has made a significant announcement regarding its quarterly cash dividend. The company's Board of Directors has declared a dividend of $0.20 per share on common stock, underscoring its commitment to returning value to...

Continue Reading